R65Q (p.Arg65Gln) variant of CASP9 (Caspase-9)
R65Q (p.Arg65Gln) in CASP9 (Caspase-9) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.47 / 1. The record also includes population frequency data and structural context.
R65Q (p.Arg65Gln) variant details
- p.Arg65Gln
- rs747615996
- NCI-TCGA Cosmic COSV6160
- cosmic curated COSV61601
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.471
- AlphaMissense 0.41
- MetaLR 0.35
- MetaSVM -0.27
- PolyPhen-2 1.00
- SIFT 0.00
- MutPred 0.51
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available